Samsung Medison partners with Intel for fetal ultrasound workflow

11 September 2020 (Last Updated September 11th, 2020 11:26)

Samsung Medison has partnered with Intel for new smart workflow solutions to enhance obstetric measurements in order to improve maternal and fetal safety.

Samsung Medison partners with Intel for fetal ultrasound workflow
Samsung Medison and Intel are collaborating on new smart workflow solutions to improve obstetric measurements that contribute to maternal and fetal safety. Credit: Samsung Medison.

Samsung Medison has partnered with Intel for new smart workflow solutions to enhance obstetric measurements in order to improve maternal and fetal safety.

As part of the partnership, Samsung Medison’s BiometryAssist will leverage an Intel Core i3 processor, the Intel Distribution of OpenVINO toolkit and OpenCV library to automate and simplify fetal measurements.

These Intel technologies also enable the company’s LaborAssist to automatically identify the fetal angle of progression (AoP) during labour, offering a full understanding of a patient’s birthing progress while eliminating the need for invasive digital vaginal exams.

Intel Health and Life Sciences strategic marketing director Claire Celeste Carnes said: “At Intel, we are focused on creating and enabling world-changing technology that enriches the lives of every person on Earth.

“We are working with companies like Samsung Medison to adopt the latest technologies in ways that enhance the patient safety and improve clinical workflows, in this case, for the important and time-sensitive care provided during pregnancy and delivery.”

According to the World Health Organization (WHO), approximately 295,000 women died during and following pregnancy and childbirth in 2017, even as maternal mortality rates decreased.

Research from the Perinatal Institute found that tracking fetal growth is vital for good prenatal care. It can help prevent stillbirths when physicians are able to recognise growth restrictions.

Samsung Medison corporate vice-president and Product Strategy head Won-Chul Bang said: “Samsung is working to improve the efficiency of new diagnostic features, as well as healthcare services, and the Intel Distribution of OpenVINO toolkit and OpenCV library have been a great ally in reaching these goals.”

BiometryAssist and LaborAssist were granted Class II clearance by the Food and Drug Administration (FDA) this year. These solutions are already in use in 80 countries, including Korea, Italy, Brazil, France, Russia and the US.

Samsung Medison will continue its partnership with Intel to further advance its ultrasounds by leveraging artificial intelligence (AI) and advanced technologies.

The company’s portfolio of ultrasound solutions includes Nerve Tracking, SW Beamforming and AI Module.

In 2018, Samsung Medison launched its premium ultrasound system HERA W10, along with the prototype of a chair-type ultrasound device HERA I10.